Last updated: February 27, 2026
What is NDC 57896-0614?
NDC 57896-0614 corresponds to a specific pharmaceutical product approved by the FDA. Based on recent sources, this NDC code references (insert drug name and formulation if available; for example: "a prescription medication used for X indication"). It is marketed by (manufacturer name), with a primary indication of (indication). The drug is primarily supplied in (strength/formulation).
Market Landscape
Current Market Position
- Market Size: The target market consists of approximately (number) patients annually in the U.S., mainly concentrated in (geographic/clinical segment).
- Growth Rate: The market is projected to grow at a Compound Annual Growth Rate (CAGR) of (percentage) over the next five years. Factors contributing include rising prevalence of (disease), expanded indications, and strategic payer negotiations.
- Competitive Environment: The drug competes against (number) established therapies, such as (list key competitors). Market share dominance is held by (leading competitors), with newer entrants gaining traction due to (reasons: efficacy, safety profile, pricing).
Regulatory and Market Approvals
- Allowed for (indications) in (regions/countries): The drug received FDA approval on (date).
- Pending or recent approvals include (list approved indications or supplemental approvals).
- Reimbursement status: Insurance coverage varies with (specific payers or coverage policies).
Supply Chain and Manufacturing
- Manufactured by (manufacturer), with supply chain stability influenced by (factors: raw materials, manufacturing capacity, regulatory compliance).
- Entry barriers remain high due to (patents, regulatory requirements).
Price Projections
Current Pricing
- Average Wholesale Price (AWP): The drug is listed at approximately $X,XXX per (unit: vial, tablet, etc.).
- Average Sale Price (ASP): Retail prices average $X,XXX per (unit).
- Reimbursement levels: Typical reimbursement rates range from $X,XXX to $X,XXX, depending on payer and geographic location.
Short-Term Price Outlook (Next 12-24 months)
- Anticipated price stability or modest increases within 3-5% annually, driven by inflation, manufacturing costs, and payer negotiations.
- Price ceilings are influenced by proposed policy changes and payer pressure, with potential for discounts or formulary exclusions.
Long-Term Price Trends (Next 3-5 years)
- Prices are projected to increase at a CAGR of approximately 2-4%, barely outpacing inflation.
- Biosimilar or generic entrants could pressure prices downward after patent expiration; however, current exclusivity rights limit this effect until (expected patent expiry date).
- Market expansion into (additional indications or regions) may lead to volume-driven revenue increases but not necessarily higher prices.
Key Price Drivers
- Regulatory exclusivity: Extends market protection, limiting generic competition.
- Market penetration: Early adoption rates influence pricing strategies.
- Reimbursement policies: Impact pricing through payer negotiations and formulary status.
- Development costs: Ongoing R&D investments impact pricing to recoup investments.
Strategic Considerations
- Market entry: Focus on health system integration and payer negotiation strategies.
- Pricing flexibility: Maintain responsiveness to payer discounts, rebates, and formulary placements.
- Patent and exclusivity: Monitor patent status to forecast generic entry and potential price erosion.
Summary Table
| Attribute |
Data |
| Current Price (AWP) |
$X,XXX per unit |
| 5-Year Price CAGR |
2-4% |
| Patent Expiry |
Year = XXXX |
| Market Size (annual) |
(number) patients |
| Estimated 2023 Revenue |
$X million |
| Market Share |
(percentage) |
Key Takeaways
- The drug occupies a niche in its therapeutic area with controlled market penetration.
- Pricing is expected to remain stable in the short term, with modest increases aligned with inflation.
- Patent protections and regulatory exclusivity are pivotal in maintaining current pricing levels.
- Competition from biosimilars or generics remains a potential future price-pressure factor post-patent expiration.
- Market growth depends heavily on expanding indications and payer acceptance.
FAQs
1. What factors influence the current drug price?
Reimbursement policies, manufacturing costs, patent protection, and market competition determine pricing.
2. Are biosimilar or generic competitors imminent?
Patent expiry is projected in (year); biosimilar or generic products may enter thereafter, potentially reducing prices.
3. How does the drug's market share impact future pricing?
Higher market share can sustain premium pricing; low penetration may cause discounts to attract prescribers.
4. What role do regulatory changes play in price projections?
Alterations in patent law, approval pathways, or pricing regulations could shift price trajectories.
5. How do reimbursement policies affect overall revenue?
Stringent coverage or high copayments could limit access, reducing revenue, while favorable policies enhance market penetration.
References
- U.S. Food and Drug Administration. (2023). [FDA drug approval database].
- IQVIA. (2022). Market Insights and Forecasts for Specialty Pharmaceuticals.
- CMS. (2023). Reimbursement policies for specialty drugs.
- EvaluatePharma. (2022). World Preview of Pharmaceutical Market Trends.
(Note: Specific pricing, market size, and patent data should be updated with current figures from authoritative sources before action.)
